Specifically, a non-oncogenetic mutation of APOB is observed, which can cause APOB inactivation and is correlated with overexpression of oncogenic regulators and downregulation of tumor suppressors, leading to worse outcomes of survival. The gene discussed is APOB; the disease is neoplasm.